Angina: A missed medical opportunity

Best initial management of stable angina starts with correct assessment; lifestyle management, anti-ischaemic drugs and prevention of adverse CV events are key, the role of revascularisation is now confined to specific subgroups

You will learn:
That angina patients are often mis-assessed in terms of symptom management and risk classification
The factors that contribute to the development of angina
The decreasing role for revascularisation in favour of optimal medical therapy for the treatment of angina
Practical recommendations for selecting anti-ischaemic drugs and for secondary prevention with antithrombotic therapy.


ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.

To access this module, please register or login: